The program brought together prominent corporate governance leaders to participate in in-depth, interactive peer group exchanges via a two roundtable sessions during the day. Keynote speaker Keith Wandell, President and CEO of Harley-Davidson, Inc. also was a highlight of the program. Included below are program materials and takeaways.
Contact us at ndi@foley.com for more information.
Related Insights
July 22, 2025
Health Care Law Today
GLP-1 Receptor Agonists: Clinical Trial Considerations
The U.S. Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide (Victoza®), semaglutide (Ozempic®, Wegovy®), and tirzepatide (Mounjaro®, Zepbound®).
July 21, 2025
Energy Current
DOE Announces Pilot Program to Build Advanced U.S. Nuclear Fuel Supply Lines: What You Need to Know Now
Introduction Coming on the heels of its June 2025 announcement establishing a pilot program for reactor construction and operation in…
July 21, 2025
Labor & Employment Law Perspectives
Considering a Reduction in Force? Some Preliminary Considerations
Employers sometimes find it necessary to make the difficult decision to undergo a reduction-in-force (RIF), resulting in employee layoffs…